OSH - Oak Street Health - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Oak Street Health's activity chart (see below) currently has 97 price targets and 81 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 50.79% of the time, taking 93.53 days on average.

Most recent stock forecast was given by JUSTIN LAKE from WOLFE on 21-Mar-2023. First documented stock forecast 31-Aug-2020.

Best performing analysts who are covering OSH - Oak Street Health:

David Macdonald Sean Wieland John Ransom Matthew Gillmor Jamie Perse

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Mar-2023

$62

3 years 7 months 26 days ago
(21-Mar-2023)

1/1 (100%)

$9 (16.98%)

14

Buy Since 15-Mar-2023

$39

3 years 8 months 1 days ago
(15-Mar-2023)

1/3 (33.33%)

$3.44 (9.67%)

47

Buy Since 31-Aug-2020

$39

$52

3 years 8 months 24 days ago
(23-Feb-2023)

2/2 (100%)

$3.56 (10.05%)

49

Buy Since 21-May-2021

$39

3 years 9 months 1 days ago
(15-Feb-2023)

1/2 (50%)

$3.62 (10.23%)

75

Buy Since 10-Feb-2023

$35

3 years 9 months 6 days ago
(10-Feb-2023)

2/4 (50%)

$5.06 (16.90%)

207

Show more analysts

Please expand the browser size to see the chart

What is OSH (Oak Street Health) average time for price targets to be met?

On average it took 94 days for the stock forecasts to be reached, with an average price target met ratio of 50.79%.

Which analyst most recently updated their price target on OSH (Oak Street Health)?

Justin Lake

Which analyst has the most public recommendations on OSH (Oak Street Health)?

Justin Lake works at WOLFE and has 5 price targets and 3 ratings on OSH

Which analyst is the currently most bullish on OSH (Oak Street Health)?

Robert Jones with the highest potential upside of $35

Which analyst is the currently most reserved on OSH (Oak Street Health)?

Kevin Fischbeck with the lowest potential downside of -$21
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?